These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20455595)

  • 1. Circulating autoantibodies to phosphorylated α-enolase are a hallmark of pancreatic cancer.
    Tomaino B; Cappello P; Capello M; Fredolini C; Sperduti I; Migliorini P; Salacone P; Novarino A; Giacobino A; Ciuffreda L; Alessio M; Nisticò P; Scarpa A; Pederzoli P; Zhou W; Petricoin Iii EF; Liotta LA; Giovarelli M; Milella M; Novelli F
    J Proteome Res; 2011 Jan; 10(1):105-12. PubMed ID: 20455595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated alpha-enolase induces autoantibodies in HLA-DR8 pancreatic cancer patients and triggers HLA-DR8 restricted T-cell activation.
    Capello M; Caorsi C; Bogantes Hernandez PJ; Dametto E; Bertinetto FE; Magistroni P; Rendine S; Amoroso A; Novelli F
    Immunol Lett; 2015 Sep; 167(1):11-6. PubMed ID: 26096821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry analysis of the post-translational modifications of alpha-enolase from pancreatic ductal adenocarcinoma cells.
    Zhou W; Capello M; Fredolini C; Piemonti L; Liotta LA; Novelli F; Petricoin EF
    J Proteome Res; 2010 Jun; 9(6):2929-36. PubMed ID: 20433201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibody signature in human ductal pancreatic adenocarcinoma.
    Tomaino B; Cappello P; Capello M; Fredolini C; Ponzetto A; Novarino A; Ciuffreda L; Bertetto O; De Angelis C; Gaia E; Salacone P; Milella M; Nisticò P; Alessio M; Chiarle R; Giuffrida MG; Giovarelli M; Novelli F
    J Proteome Res; 2007 Oct; 6(10):4025-31. PubMed ID: 17824682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
    Chung JC; Oh MJ; Choi SH; Bae CD
    ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models.
    Capello M; Cappello P; Linty FC; Chiarle R; Sperduti I; Novarino A; Salacone P; Mandili G; Naccarati A; Sacerdote C; Beghelli S; Bersani S; Barbi S; Bassi C; Scarpa A; Nisticò P; Giovarelli M; Vineis P; Milella M; Novelli F
    J Hematol Oncol; 2013 Sep; 6():67. PubMed ID: 24010981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.
    Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM
    Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
    Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
    Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards pancreatic cancer diagnosis using EIS biochips.
    Chiriacò MS; Primiceri E; Monteduro AG; Bove A; Leporatti S; Capello M; Ferri-Borgogno S; Rinaldi R; Novelli F; Maruccio G
    Lab Chip; 2013 Feb; 13(4):730-4. PubMed ID: 23287869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
    Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
    Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen.
    Cappello P; Tomaino B; Chiarle R; Ceruti P; Novarino A; Castagnoli C; Migliorini P; Perconti G; Giallongo A; Milella M; Monsurrò V; Barbi S; Scarpa A; Nisticò P; Giovarelli M; Novelli F
    Int J Cancer; 2009 Aug; 125(3):639-48. PubMed ID: 19425054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of plasma Tu-M2-PK and CA19-9 in pancreatic cancer.
    Joergensen MT; Heegaard NH; Schaffalitzky de Muckadell OB
    Pancreas; 2010 Mar; 39(2):243-7. PubMed ID: 19820423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum CA19-9, cathepsin D, and matrix metalloproteinase-7 as a diagnostic panel for pancreatic ductal adenocarcinoma.
    Park HD; Kang ES; Kim JW; Lee KT; Lee KH; Park YS; Park JO; Lee J; Heo JS; Choi SH; Choi DW; Kim S; Lee JK; Lee SY
    Proteomics; 2012 Dec; 12(23-24):3590-7. PubMed ID: 23065739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas.
    Qi T; Han J; Cui Y; Zong M; Liu X; Zhu B
    J Clin Pathol; 2008 Jan; 61(1):49-58. PubMed ID: 17412869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proteome analysis of autoantibodies in sera of patients with cancer].
    Ueda K
    Rinsho Byori; 2005 May; 53(5):437-45. PubMed ID: 15966408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence of pancreatic ductal adenocarcinoma specific autoantibodies to Ezrin in a liquid phase LIPS immunoassay.
    Liberati D; Marzinotto I; Brigatti C; Dugnani E; Pasquale V; Reni M; Balzano G; Falconi M; Piemonti L; Lampasona V
    Cancer Biomark; 2018; 22(2):351-357. PubMed ID: 29660901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis.
    Saulot V; Vittecoq O; Charlionet R; Fardellone P; Lange C; Marvin L; Machour N; Le Loët X; Gilbert D; Tron F
    Arthritis Rheum; 2002 May; 46(5):1196-201. PubMed ID: 12115223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of serum parameters panels for the early detection of pancreatic cancer.
    Zhang P; Zou M; Wen X; Gu F; Li J; Liu G; Dong J; Deng X; Gao J; Li X; Jia X; Dong Z; Chen L; Wang Y; Tian Y
    Int J Cancer; 2014 Jun; 134(11):2646-55. PubMed ID: 24615168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma.
    Hwang TL; Liang Y; Chien KY; Yu JS
    Proteomics; 2006 Apr; 6(7):2259-72. PubMed ID: 16493704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications and diagnostic usefulness of correlation between soluble major histocompatibility complex class I chain-related molecule a and protumorigenic cytokines in pancreatic ductal adenocarcinoma.
    Chung HW; Jang S; Lim JB
    Cancer; 2013 Jan; 119(1):233-44. PubMed ID: 22736451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.